Exercise capacity · people with pulmonary hypertension
2 findings from 1 review
Exercise capacity: peak power watts · people with pulmonary hypertension
1 finding from 1 review
Serious adverse events · people with pulmonary hypertension
Exercise showed no clear difference in serious adverse events compared with control (moderate certainty).
1 finding from 1 review
HRQoL SF‐36: PCS units · people with pulmonary hypertension
1 finding from 1 review
HRQoL SF‐36: MCS units · people with pulmonary hypertension
1 finding from 1 review
Cardiopulmonary haemodynamics (mPAP) mmHg · people with pulmonary hypertension
1 finding from 1 review
Fatigue · people receiving dialysis
1 finding from 1 review
Weakness · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Energy · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Tiredness · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Exhaustion · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Asthenia · people receiving dialysis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at end of intervention (range 2–10 months) · adult patients after liver transplantation.
It is very uncertain whether exercise changes all‐cause mortality at end of intervention (range 2–10 months) compared with control (very low certainty).
1 finding from 1 review
Serious adverse events (excluding deaths) at 26 weeks · adult patients after liver transplantation.
1 finding from 1 review
Health‐related quality of life (physical) · adult patients after liver transplantation.
1 finding from 1 review
Aerobic capacity · adult patients after liver transplantation.
1 finding from 1 review
Muscle strength · adult patients after liver transplantation.
1 finding from 1 review
Non‐serious adverse events (range 2–10 months) · adult patients after liver transplantation.
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · adolescents and adults with cystic fibrosis
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found